Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI265

Protection against myocardial dysfunction after a brief ischemic period in transgenic mice expressing inducible heat shock protein 70.

S U Trost, J H Omens, W J Karlon, M Meyer, R Mestril, J W Covell, and W H Dillmann

Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0618, USA.

Find articles by Trost, S. in: PubMed | Google Scholar

Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0618, USA.

Find articles by Omens, J. in: PubMed | Google Scholar

Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0618, USA.

Find articles by Karlon, W. in: PubMed | Google Scholar

Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0618, USA.

Find articles by Meyer, M. in: PubMed | Google Scholar

Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0618, USA.

Find articles by Mestril, R. in: PubMed | Google Scholar

Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0618, USA.

Find articles by Covell, J. in: PubMed | Google Scholar

Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0618, USA.

Find articles by Dillmann, W. in: PubMed | Google Scholar

Published February 15, 1998 - More info

Published in Volume 101, Issue 4 on February 15, 1998
J Clin Invest. 1998;101(4):855–862. https://doi.org/10.1172/JCI265.
© 1998 The American Society for Clinical Investigation
Published February 15, 1998 - Version history
View PDF
Abstract

Brief ischemic periods lead to myocardial dysfunction without myocardial infarction. It has been shown that expression of inducible HSP70 in hearts of transgenic mice leads to decreased infarct size, but it remains unclear if HSP70 can also protect against myocardial dysfunction after brief ischemia. To investigate this question, we developed a mouse model in which regional myocardial function can be measured before and after a temporary ischemic event in vivo. In addition, myocardial function was determined after brief episodes of global ischemia in an isolated Langendorff heart. HSP70-positive mice and transgene negative littermates underwent 8 min of regional myocardial ischemia created by occlusion of the left descending coronary artery, followed by 60 min of reperfusion. This procedure did not result in a myocardial infarction. Regional epicardial strain was used as a sensitive indicator for changes in myocardial function after cardiac ischemia. Maximum principal strain was significantly greater in HSP70-positive mice with 88+/-6% of preischemic values vs. 58+/-6% in transgene-negative mice (P < 0.05). Similarly, in isolated Langendorff perfused hearts of HSP70-positive and transgene-negative littermates exposed to 10 min of global ischemia and 90 min of reperfusion, HSP70 transgenic hearts showed a better-preserved ventricular peak systolic pressure. Thus, we conclude that expression of HSP70 protects against postischemic myocardial dysfunction as shown by better preserved myocardial function.

Version history
  • Version 1 (February 15, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts